Stay updated on Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Sign up to get notified when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.

Latest updates to the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, indicating a site release update.SummaryDifference0.1%

- Check8 days agoChange DetectedA sitewide notice appears above the study record describing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.7%

- Check15 days agoChange DetectedThe website footer revision label changes from v3.7.1 to v3.7.2, with no change to the study record content.SummaryDifference0.1%

- Check22 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history reflects a new site revision v3.7.0 being added and an older revision v3.6.6 being removed, indicating a software update to the page rather than a change to the clinical trial data.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a recent system release rather than modifications to study data.SummaryDifference0.1%

Stay in the know with updates to Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.